BLRX BioLineRx Ltd. - American Depositary Shares
BLRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
BLRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
BLRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-08-14Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Sept. 30, 2024 | $-0.07 | — | — |
| March 31, 2024 | $-0.01 | — | — |
| Sept. 30, 2023 | $-0.30 | — | — |
| Sept. 30, 2015 | $-0.12 | $-0.08 | -0.04% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BLRX | — | — | — | — | — | — |
| CGEN | — | — | — | — | — | — |
| ENLV | — | — | — | — | — | — |
| PLRZ | — | — | — | — | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 15 filers · $269K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (+2 vs prior Q) | 3 (+1 vs prior Q) | 2 (+1 vs prior Q) | 4 (+1 vs prior Q) | +56K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $120,900 | 39,000 | 44.99% | Call option |
| RENAISSANCE TECHNOLOGIES LLC | $48,085 | 15,412 | 17.89% | Shares |
| CITADEL ADVISORS LLC | $45,868 | 14,796 | 17.07% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $36,726 | 11,847 | 13.67% | Shares |
| RHUMBLINE ADVISERS | $7,679 | 2,478 | 2.86% | Shares |
| WELLS FARGO & COMPANY/MN | $5,460 | 1,750 | 2.03% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,550 | 500 | 0.58% | Shares |
| Banque Cantonale Vaudoise | $1,000 | 1 | 0.37% | Shares |
| Nemes Rush Group LLC | $780 | 250 | 0.29% | Shares |
| UBS Group AG | $315 | 101 | 0.12% | Shares |
| NewEdge Advisors, LLC | $256 | 82 | 0.10% | Shares |
| OSAIC HOLDINGS, INC. | $81 | 26 | 0.03% | Shares |
| SBI Securities Co., Ltd. | $31 | 10 | 0.01% | Shares |
| DANSKE BANK A/S | $6 | 2 | 0.00% | Shares |
| CITIGROUP INC | $3 | 1 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Hong Seng Technology Limited, Lepu (Hong Kong) Co., Limited, Lepu Holdings Limited, Lepu Medical (Europe) Cooperatief U.A., Lepu Medical Technology (Beijing) Co., Ltd. | Oct. 26, 2023 | — | Initial filing | — | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BIOTECHNOLOGY VALUE FUND II, L.P., BIOTECHNOLOGY VALUE TRADING FUND OS LP, BVF PARTNERS OS LTD., BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT ×2 filings | March 1, 2019 | — | Initial filing | — | SEC |
| PAN ATLANTIC BANK AND TRUST LIMITED, FCMI FINANCIAL CORPORATION, ALBERT D. FRIEDBERG ×8 filings | March 8, 2017 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.